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Abstract: Rodent-borne hantaviruses can cause two human diseases with many pathological
similarities: hantavirus cardiopulmonary syndrome (HCPS) in the western hemisphere and
hemorrhagic fever with renal syndrome in the eastern hemisphere. Each virus is hosted by specific
reservoir species without conspicuous disease. HCPS-causing hantaviruses require animal biosafety
level-4 (ABSL-4) containment, which substantially limits experimental research of interactions
between the viruses and their reservoir hosts. Maporal virus (MAPV) is a South American hantavirus
not known to cause disease in humans, thus it can be manipulated under ABSL-3 conditions.
The aim of this study was to develop an ABSL-3 hantavirus infection model using the deer mouse
(Peromyscus maniculatus), the natural reservoir host of Sin Nombre virus (SNV), and a virus that
is pathogenic in another animal model to examine immune response of a reservoir host species.
Deer mice were inoculated with MAPV, and viral RNA was detected in several organs of all deer
mice during the 56 day experiment. Infected animals generated both nucleocapsid-specific and
neutralizing antibodies. Histopathological lesions were minimal to mild with the peak of the lesions
detected at 7–14 days postinfection, mainly in the lungs, heart, and liver. Low to modest levels of
cytokine gene expression were detected in spleens and lungs of infected deer mice, and deer mouse
primary pulmonary cells generated with endothelial cell growth factors were susceptible to MAPV
with viral RNA accumulating in the cellular fraction compared to infected Vero cells. Most features
resembled that of SNV infection of deer mice, suggesting this model may be an ABSL-3 surrogate for
studying the host response of a New World hantavirus reservoir.
Keywords: hantavirus; Maporal virus; deer mice; reservoir; zoonoses
1. Introduction
Hantaviruses are negative-stranded, trisegmented members of the Bunyaviridae family that are
hosted by rodents, insectivores, or bats [1,2]. Several pathogenic hantaviruses, all of which are
hosted by rodents, can cause hemorrhagic fever with renal syndrome (HFRS) in Eurasia, or hantavirus
cardiopulmonary syndrome (HCPS) in the Americas [3,4]. Although the principal target organs of these
diseases differ, both infect the endothelium and share many pathologic similarities that lead to fluid
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loss and electrolyte imbalances, suggesting the underlying disease mechanisms are similar [5,6]. Some
evidence suggests a role for the immune response in pathogenesis of hantavirus disease [7–9], but a role
for lymphocytes is unclear [10,11]. The principal cellular target of hantaviruses are vascular endothelial
cells but without conspicuous effects on those cells, although vascular leakage is a prominent feature
of hantavirus disease [12].
Deer mice (Peromyscus maniculatus) are the principal reservoir hosts of Sin Nombre virus
(SNV) [13–15], the etiologic agent of most HCPS cases in North America [1,4]. Inoculation of deer mice
with SNV results in persistent infection without signs of clinical disease, and neutralizing antibodies
appear after three weeks; however, they are insufficient for clearing virus [16–18]. Early immune
markers suggest a subtle Th1/Th2 response, followed by signatures of regulatory T cell responses that
may impair cytotoxic T cell activities and contribute to persistent infection [18–20].
Experimental infection of deer mice with Andes virus (ANDV) results in an apathogenic
infection but, in contrast, a robust immune response occurs that is associated with clearance within
several weeks [20,21]. The immune response is characterized by prominent expression of Th2 and T
follicular helper cell genes, STAT1 (signal transducer and activator of transcription 1) phosphorylation,
interleukin (IL)-4 pathway genes and, to a lesser extent, Th1 genes, and earlier seroconversion
suggesting a rapid maturation of the IgG response.
Human pathogenic New World hantaviruses, such as SNV and ANDV, require animal biosafety
level-4 (ABSL-4) containment [22]. Maporal virus (MAPV) is closely related to ANDV and was first
isolated from a fulvous pygmy rice rat (Oligoryzomys fulvescens) captured in Venezuela [23]; however,
subsequent work identified the delicate pygmy rice rat (O. delicatus) as the principal reservoir host [24].
Similar to ANDV, and unlike SNV, MAPV causes an HCPS-like disease in experimentally infected
Syrian hamsters (Mesocricetus auratus) [25]. Because MAPV is not known to cause disease in humans,
it can be used in experimental infections with ABSL-3 precautions.
We were interested in determining if deer mice are susceptible to MAPV and, if so, whether they
developed clinical disease (like hamsters), cleared infection (like ANDV), or remained persistently
infected (like SNV). We inoculated deer mice with MAPV and detected virus in the lungs 2 days
later and until the termination of the experiment on day 56. MAPV-specific antibodies were detected
in deer mice as early as 14 days postinfection (PI). Viral RNA was also detected in the lungs, heart,
spleen, kidney, liver, and salivary glands 14 days after inoculation. Although no conspicuous signs of
disease were observed, we found indications of mild pathology in several organs upon histological
examination. We also found that deer mouse pulmonary cells propagated in endothelial cell medium
were susceptible to MAPV infection and that virus may transmit directly to adjacent cells. Many
of these characteristics more closely resemble SNV infection of deer mice than ANDV infection.
Thus, MAPV infection of deer mice offers a suitable ABSL-3 system in which to study the host response
of a reservoir of a New World hantavirus with pathogenic potential.
2. Materials and Methods
2.1. Ethics Statement
All procedures using deer mice were in compliance with the U.S. Animal Welfare Act
and approved by the Colorado State University institutional animal care and use committee
(protocol 13-4377A) and performed by following the guidelines of the Association for Assessment
and Accreditation of Laboratory Animal Care, International (AAALAC), by certified staff in an
AAALAC-approved facility.
2.2. Experimental Infections
Deer mice of both sexes and aged 8–16 weeks were used for this study. All procedures with
MAPV were approved by the Colorado State University Institutional Biosafety Committee. MAPV HV
97021050 (kindly provided by D. Safronetz, Rocky Mountain Laboratories, NIAID) was propagated in
Vero E6 cells (ATCC CRL-1586). In the initial susceptibility testing, 10 deer mice (5 males, 5 females)
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were subcutaneously inoculated in the left hindquarters with 104 50% tissue culture infectious dose
(TCID50) MAPV, and two deer mice (1 male, 1 female) were sham-inoculated with sterile PBS. On days 2,
4, 7, 14, and 56, one male and one female were euthanized for blood collection, necropsy, and tissue
retrieval. Tissues for RNA extraction were immediately placed in liquid nitrogen, then stored at
−80 ◦C, whereas tissues for histopathology were placed in 10% buffered formalin.
In a second experiment, five male deer mice were inoculated as described in the susceptibility
experiment, and were euthanized 14 days after infection for examination of viral infection by PCR
and immunohistochemistry (IHC), immune gene expression, and for histopathology of lungs, hearts,
spleens, kidneys, livers, and salivary glands.
2.3. Tissue Processing
Tissues were prepared for histopathology and immunochemistry as previously described [18].
Tissues were sectioned and stained with hematoxylin–eosin with at least 2 sections examined blindly
per tissue. Both heart ventricles were sectioned, including the septum. Five uninfected control
animals (day 14) were also examined. Scoring was 0–3 and performed under high-power (40×)
microscopic fields (HPMF) for no lesions (−), presence of fewer than 5 necrotic/degenerate (N/D) cells
and 5–10 inflammatory cells (IC) (+/−), 5–10 and N/D 10–25 IC (+), and >10 N/D and >25 IC (++).
For IHC, polyclonal rabbit anti-SNV nucleocapsid antiserum (kindly provided by B. Hjelle, University
of New Mexico Medical Center) that we have previously used with SNV-infected deer mice [18] and
that is cross-reactive with ANDV [21] was used to detect viral antigen.
Virus isolation was attempted from tissues by preparing homogenates with stainless steel beads
in 5% FBS–DMEM (TissueLyser LT, Qiagen, Valencia, CA, USA). Samples were homogenized 2 × 5 min
at 2 Hz, and then centrifuged at 3000 rpm for 5 min at 4 ◦C. Four hundred microliters of the supernatant
was added to 500 µL 5% FBS–DMEM and filtered through 0.2 µm Acrodisc filter and 100 µL of filtrate
inoculated onto confluent Vero E6 cells in 24 well plates. Medium was harvested on day 7 and RNA
was extracted from supernatants (QIAamp Viral RNA Mini kit, Qiagen) according to manufacturer’s
instructions. One-step PCR was performed and sample run on 1% agarose gels.
2.4. ELISA
A previously described protein-A/G–HRP (horseradish peroxidase) enzyme immunoassay was
used to detect IgG [26]. Briefly, a truncated SNV nucleocapsid antigen containing a highly conserved
epitope [27] was diluted to 1 µg/mL in PBS (pH 7.2) and 100 µL added to wells of a 96-well polyvinyl
chloride (PVC) microtiter plate (BD Falcon, Franklin Lakes, NJ, USA) that was incubated overnight
at 4 ◦C. The next day, the plate was washed with PBS, then blocked (SuperBlock T20, Thermo Scientific,
Waltham, MA, USA). After washing, serum samples were diluted to 1:100 in PBS, then further diluted
(log2) to determine endpoint titers. Sera were incubated for 1 h at room temperature, then washed 4×
in PBS-0.5% TWEEN20. Protein-A/G–HRP (32490, Thermo Scientific) conjugate (1:5000) was incubated
for 1 h at room temperature, followed by washing and the addition of ABTS substrate (50-62-00, KPL,
Gaithersburg, MD, USA) for 15 min. Absorbances at 405 nm were recorded (model 450, Bio-Rad,
Hercules, CA, USA). Samples with readings 0.200 above the mean of the negative control serum
samples were considered positive. Endpoint titers were calculated as the reciprocal of the greatest
dilution that yielded a positive result, and the geometric means (GMT) and standard deviations
(SD) plotted.
2.5. Serum Neutralization Assay
Sera from the infected deer mice were diluted 1:20 in 2% FBS–DMEM, then diluted log2 in
final volumes of 100 µL [18]. MAPV was diluted to 103 TCID50/mL and 100 µL added to the serial
serum dilutions (1:2 dilution) and incubated for 1 h at room temperature. The 200 µL volumes
were then pipetted onto Vero E6 cells monolayered on cover slips in 24-well plates and incubated
for 1 h at 37 ◦C, followed by the addition of 800 µL of 2% FBS–DMEM. Plates were incubated
for 7 days, then fixed in 2% buffered formalin, followed by detection of viral antigen using rabbit
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anti-SNV nucleocapsid-specific antiserum. Goat anti-rabbit IgG–FITC conjugate was incubated for 2 h.
Coverslips were mounted on microscope slides with DAPI (ProLong Gold, Life Technologies, Foster
City, CA, USA) for visualization by fluorescent microscopy. The reciprocal of the greatest dilution of
serum that blocked infection was considered the endpoint titer.
2.6. Detection of Viral RNA in Tissues
A qualitative reverse-transcription PCR assay was used to detect viral RNA. Total RNA
was extracted (RNEasy kit, Qiagen) and used for PCR (OneStep RT-PCR kit, Qiagen). Primers
used were from the MAPV S segment, 5′-AGCTGTGATGAGCAACCTCC-3′ (forward) and
5′-CAATTGGCACAAGCCCGAAA-3′ (reverse) with 95 ◦C melting (30′′), 58 ◦C annealing (30′′),
and 72 ◦C extension (60′′) for 35 cycles. Amplicons were resolved on agarose gels and also sequenced
to verify MAPV.
2.7. Cytokine PCR
Real-time PCR for cytokine and chemokine gene expression in lungs and spleens was performed
as previously described [18,20,28]. Briefly, total RNA was reverse transcribed to synthesize cDNA
for amplification of transcripts (Two-Step Go-Taq SYBR Green, Promega, Madison, WI, USA) to
determine relative fold changes using the ∆∆Ct method [29]. Gapdh (glyceraldehyde-3-phosphate
dehydrogenase) was used in duplicate as within-sample normalization control (∆Ct), followed by
comparison of the same gene between infected deer mice and the mean ∆Ct of two uninfected
control RNA samples (∆∆Ct). Fold-changes of each gene from each animal were determined and
95% confidence intervals calculated to provide margins of error for each gene. Error bars that do not
overlap are considered statistically significant using this method. Heat maps and hierarchical clusters
were generated with R statistical software (http://www.r-project.org/) using the heatmap.2 (gplots)
package [30].
2.8. Generation of Deer Mouse Pulmonary Microvascular Endothelial Cells
Seven day old deer mice were euthanized for retrieval of lungs and isolation of pulmonary
microvascular endothelial cells (PMVEC) using a modified strategy [31]. Lungs were aseptically
minced with a sterile scalpel and incubated with a collagenase/elastase cocktail (E7885, C1639, Sigma,
St. Louis, CA, USA) for 1 h at 4 ◦C with gentle tumbling on an orbital mixer. Digested tissue suspension
was then aspirated into a 30 mL syringe and slowly expelled through a 20 gauge needle to separate
tissue clumps into a single cell suspension. This was repeated 12 times to ensure maximum separation.
Fifteen milliliters of 20% FBS–DMEM was added to stop enzymatic activities. Particulates were
allowed to briefly settle and the cell suspension was collected and washed in 0.1% BSA DPBS, and
then resuspended in 3 mL of endothelial cell medium (ECM; VascuLife EnGS-Mv Life Factors kit,
10% ∆H FBS, LL-0004, Lifeline Cell Technologies, Oceanside, CA, USA). T-75 flasks were coated with
bovine skin gelatin (G1393, Sigma) and allowed to dry. Cells were plated in gelatin-coated T-75 flasks
at 2.1 × 106 cells in 10 mL of 10% FBS–ECM. Because of their rapid replication, cells were passaged
1:20 at 4 day intervals and frozen stocks prepared.
2.9. PMVEC Infections
For infection experiments, cells were plated onto sterile glass coverslips in 24-well plates. MAPV
was diluted in 2% FBS Ham’s F12 medium and 200 µL containing 0.1 MOI (multiplicity of infection)
of virus added to wells for 1 h, followed by the addition of 800 µL of 2% FBS Ham’s F12. Cells were
incubated for 1 week, then stained for viral antigen by fluorescent microscopy as described above.
Vero E6 and PMVEC cells were plated onto 24-well plates coated with gelatin and incubated to
confluence. Cells were inoculated with 0.1 MOI of MAPV for 1 h in 200 uL at 37 ◦C. Inocula were
removed and the monolayers washed once in PBS. One milliliter of 2% FBS Ham’s F12 medium was
added to each well. One hour later, 140 µL of supernatant was collected for RNA extraction (QiaAmp
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Viral RNA kit, Qiagen). The remaining medium was removed and discarded and cellular RNA was
extracted from the monolayer (RNEasy kit, Qiagen). Additional samples were collected on days 3,
6, 9 and 12; on day 12 uninoculated samples were also collected (negative control). One-step PCR
was performed in duplicate using an RNA Virus Master kit (Roche) with 1 uL of RNA, forward
(5′ ATCAGGTTCAAGCCCTGTTG) and reverse (5′ AGGCAACTGGCAGATCTTGT) primers, and
probe (5′ FAM-TGATTCACAGCCTCCTTTCC-BHQ1a) for 40 cycles according to manufacturer’s
instructions (LightCycler 96, Roche, Pleasanton, CA, USA). TCID50 equivalents were determined
by performing a log10 dilution of RNA generated from MAPV stock to estimate vRNA abundance
in samples.
3. Results
3.1. Maporal Virus Persistently Infects Deer Mice
In the initial experiment, we inoculated deer mice with 104 TCID50 MAPV (subcutaneous, right
hindquarters) and euthanized two each on days 2, 4, 7, 14, and 56 postinoculation to determine
susceptibility and kinetics of infection in the lungs, a principal target organ of New World hantaviruses.
None of the deer mice exhibited conspicuous signs of disease, similar to SNV and ANDV infection of
deer mice [16,18,21]. PCR amplification detected MAPV sequences in all deer mice from each time
point (Figure 1a), suggesting persistent infection. Attempts to isolate MAPV in Vero E6 cells were not
successful. ELISA specific for nucleocapsid antigen showed that one deer mouse had seroconverted
on day 14, as had both deer mice euthanized on day 56 (Figure 1b). None of the other deer mice
had antibodies by ELISA. Neutralizing antibodies were only detected in the deer mice euthanized on
day 56, with titers of 320 for each. 
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Figure 1. Maporal virus (MAPV) infects deer mice. After subcutaneous inoculation in the hindquarter,
MAPV RNA was detected in the lungs two days later and persisted though at least 56 days; M marker,
BP base pairs, -K negative control (a). Antibodies to MAPV nucleocapsid appeared as early as 14 days
PI and increased in titer by day 56 (b).
In a second experiment to determine tissue distribution of MAPV, five male deer mice were
inoculated and euthanized 14 days PI. Viral RNA was detected by PCR in lungs, heart, spleen, kidney,
liver and salivary glands of all five deer mice, a disseminated pattern similar to that found in some,
but not all, deer mice persistently infected with SNV [17].
3.2. Histopathology and Immunohistochemistry
At necropsy, organs of all deer mice appeared normal upon gross examination. Histopathologic
lesions were detected in the lungs, liver, heart, and salivary glands of all infected animals to varying
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degrees (Figure 2, Table 1). At days 2, 4, and 56 PI, at least one infected deer mouse showed congestion
of alveolar capillaries with multifocal pulmonary hemorrhages and minimal perivascular infiltrates of
mixed inflammatory cells, predominantly neutrophils. Variable amounts of proteinaceous edema fluid
filled small numbers of alveoli with occasional suspended macrophages. Severity of the lesions peaked
at day 7 PI, especially in the lungs, heart, and liver. Peribronchiolar and perivascular neutrophilic
infiltrates were prominent with minimal-to-mild interstitial pneumonia at 7–14 days PI. During the
same time frame, the liver showed periportal infiltrates of mixed inflammatory cells, predominantly
lymphocytes. Lesions in the heart were detected between 7 and 56 days PI and consisted of individual
cardiomyocyte degeneration and mild lymphocytic interstitial myocarditis in the vicinity of affected
cardiomyocytes. Occasionally, there was slight hypertrophy and hyperplasia of the endothelial lining
of the left atrial endocardium and coronary vessels with subendothelial lymphocytic infiltrates into
subjacent myocardium 7 days PI.
Table 1. Histopathology of deer mice infected with Maporal virus.
Mouse # DPI
Lungs Heart
Cong./Ede MIAH IP PBLH CD/apop LIM
DM 1 2 + + - - - +
DM 2 2 ++ + +/− - +/− +/−
DM 3 4 ++ + +/− + +/− +/−
DM 4 4 + - - - +/− +/−
DM 5 7 ++ - + + +/− +
DM 6 7 ++ +/− + ++ + ++
DM 7 14 +/− +/− - +/− - +/−
DM 8 14 +/− ++ +/− - - +/−
DM 9 56 + +/− +/− +/− - +/−
DM 10 56 + + - - - -
-, Negative (no histologic lesions detected in the sections examined); +/−, Minimal inflammation or
degeneration/apoptosis; +, Mild inflammation or degeneration; ++, Moderate inflammation or degeneration;
Cong. = congestion; Ede = edema; MIAH = multifocal intraalveolar hemorrhage; IP = interstitial pneumonia;
PBLH = peribronchiolar lymphoid hyperplasia; CD = cardiomyocyte degeneration; Apop = apoptosis;
LIM = lymphocytic interstitial myocarditis.
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Figure 2. Histopathology of cardiopulmonary phase of MAPV infection in deer mice. Control lung
(day 14) shows clear airways (bronchiole, B) and air spaces, normal vessels (pulmonary artery, PA)
and normal thickness of interstitium (a, 200×). Lungs 14 days PI show alveolar hemorrhage, edema,
and mild interstitial pneumonia (b, 100×). Lungs at 14 days PI show prominent perivascular (portal
vein, PV, and artery, PA) neutrophilic infiltrates with mild interstitial pneumonia (c, 400×; d, 200×).
Control heart shows a normal coronary artery and surrounding myocardium (e, 200×). Left atrium
7 days PI shows endothelial hypertrophy and hyperplasia with lymphocyte infiltration into subjacent
myocardium with sarcoplasmic hyalinization and vacuolation of sarcoplasm with loss of cross striations
(f, 400×). At 56 days PI, coronary artery (CA) with hypertrophic endothelium and perivascular edema,
interstitial lymphocytic myocarditis and cardimyocyte degeneration/necrosis (g, 400×) and necrotic
cardiomyocytes appear rounded up with hyperesinophilic sarcoplasm and pyknotic nuclei (h, 400×).
Control liver shows intact limiting plate around normal portal vessels, hepatic artery (HA) and bile
ductile (BD) (i, 200×). Focal disruption of portal vein (PV) endothelium (arrows) with lymphocytes
percolating the limiting plate (LP) into the surrounding parenchyma mixed with a few neutrophils
(j, 400×). Stain, hematoxylin-eosin.
At 56 days PI, there were scattered necrotic/apoptotic cardiomyocytes characterized by rounding
of a fragment of cardiac muscle fiber, which appeared hyalinized with loss of cross striations and
vacuolation of sarcoplasm. Single-cell apoptosis was also detected in mucous salivary glands with
minimal periductular infiltrates of lymphocytes. The spleen showed minimal to mild lymphoid
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hyperplasia, but no significant lymphocytolysis or other significant lesions. Apart from minimal
interstitial infiltrates of lymphocytes and multifocal glomerular congestion, kidneys did not show
other significant histologic lesions.
Immunohistochemical staining revealed no conspicuous immunoreactivity in any of the organs
examined, similar to what is observed in ANDV-infected deer mice [21].
3.3. Gene Expression Profiling
Infection of deer mice with SNV or ANDV results in differential expression of many genes.
We chose 10 of these genes for examination of lungs and spleens of MAPV-infected deer mice
euthanized 14 days PI, a time point where many differences exist between ANDV- and SNV-infected
deer mice [18,21], to determine whether MAPV infection more closely resembles ANDV or SNV
infection. In spleens, Ccl2, Ccl3 and Tgfb transcripts were significantly elevated, whereas Il23 was
significantly downregulated (Figure 3a). Spleen cluster analysis grouped three of the five deer mice
(DM15, DM17, DM19) whereas one infected deer mouse (DM22) clustered near the two uninfected
controls. In the lungs, Ccl3 and Cxcl2 were significantly elevated and no genes were downregulated
(Figure 3b). One gene, Il17 was not detected in the lungs of MAPV-infected or uninfected control deer
mice. In contrast to the spleen data, DM22 clustered most distantly from the other four infected deer
mice, as well as the two uninfected controls, and had the most abundant expression of Il21 and Tgfb.Viruses 2016, 8, x  4 of 6 
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Figure 3. Cytokine and chemokine gene expression in spleens and lungs of MAPV-infected deer mice.
Fourteen days post infection, spleens and lungs of 5 deer mice were examined for the expression of
10 genes by real-time PCR. Ccl2, Ccl3 and Tgfb were elevated in spleens of infected deer mice (dark
gray) compared to uninfected deer mice (light gray), whereas Il23 expression was repressed. Error
bars represent 95% confidence intervals and those denoted by * are statistically different from the
uninfected control. Heat map indicates fold-change of individual deer mice used in generating the
graph of infected deer mice (DM17–DM22) and uninfected controls (DM.C1, DM.C2) (a). In lungs,
only Ccl3 and Cxcl2 were elevated. Heat map indicates fold-change of individual deer mice used in
generating the graph of infected deer mice (DM17–DM22) and uninfected controls (DM.C1, DM.C2).
**Il17 was not detected in either infected or uninfected lung samples (b).
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3.4. Maporal Virus Infects Deer Mouse Pulmonary Cells
We cultured deer mouse pulmonary cells in endothelial cell medium to generate a primary cell
culture to test susceptibility of the cells to MAPV. For in vitro infection experiments, deer mouse
pulmonary microvascular endothelial cells (PMVEC) or Vero E6 cells were inoculated with MAPV,
incubated and stained for viral antigen on days 2, 4, and 7, and examined by fluorescent microscopy.
Microscopically, deer mouse PMVEC had substantially larger cytoplasmic area compared to Vero
E6 (Figure 4), which are of epithelial origin. Viral antigen was not detected in day 2 infected deer
mouse PMVEC, but on day 4 a few cells were antigen positive and on day 7 many more cells had
detectable punctate antigen, including clusters of neighboring cells suggestive of lateral spread of the
virus (Figure 4). Antigen was detected in some Vero E6 cells on day 2, but by day 4 punctate antigen
was detected in many cells. By day 7, antigen detection was more widespread; however, it was diffuse
instead of punctate. Detection of MAPV RNA from culture supernatants was equivocal except for
day 7 Vero, where it was >103 S segment copies/mL.Viruses 2016, 8, x  5 of 6 
 
 
Figure 4. Maporal virus infects deer mouse cells. Deer mouse pulmonary microvascular endothelial 
cells (PMVEC) or Vero E6 cells were inoculated with 0.1 MOI of MAPV. On days 2, 4 and 7 cells from 
each were fixed and stained with rabbit antibody specific to nucleocapsid and detected with a mouse 
anti‐rabbit  IgG‐FITC conjugate  (green). Slides were mounted with DAPI  to  identify nuclei  (blue). 
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Figure 4. Maporal virus infects deer mouse cells. eer ouse pulmonary microvascular endothelial
cells (PMVEC) or Vero E6 cells were inoculated ith 0.1 OI of MAPV. On days 2, 4 and 7 cells from
each were fixed and stained with rabbit antibody specific to nucleocapsid and detected with a mouse
anti-rabbit IgG-FITC conjugate (green). Slides were mounted with DAPI to identify nuclei (blue). Viral
antigen was detected in some deer mouse PMVEC on day 4 but substantially more cells by day 7, and
with punctate characteristics. Virus was detected in few Vero E6 cells on day 2, but on day 4 punctate
cells were readily observed. By day 7, many more cells were infected but the pattern was more diffuse
and less puntate.
3.5. Maporal Virus RNA Accumulates in the Cellular Fraction of Deer Mouse PMVEC
Vero E6 and deer mouse PMVEC were inoculated with 0.1 MOI of MAPV to quantify viral RNA
levels by real-time PCR in supernatants and cells (Figure 5). vRNA levels were substantially higher
in Vero E6 cells than in PMVEC. The amount of viral RNA in the Vero E6 supernatant exceeded the
amount in its cellular fractions. However, infection of PMVEC led to a greater accumulation of viral
RNA in its cellular fraction by day 6. By day 12, more than 5 logs (TCID50 equivalents) of vRNA
was detected in Vero E6 supernatants, but less than 3 logs were detected in PMVEC supernatants.
In contrast, about 4.5 logs of vRNA was detected in the Vero E6 cellular fraction and about 3.8 logs in
the PMVEC cellular fraction.
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Figure 5. Accumulation of MAPV RNA in cellular fractions of infected deer mouse PMVEC. Vero E6
(circles) and deer mouse PMVEC (squares) were infected with MAPV to examine viral RNA in cells
(hatched lines) and supernatants (solid lines) by real-time PCR. Cells were inoculated with 0.1 MOI
of MAPV for 1 h, followed by removal of inoculum, 1× wash in PBS and addition of 2% FBS Ham’s
F12 medium. The day 0 samples were collected 1 h later. The remaining samples were collected
on days 3, 6, 9 and 12 dpi. RNA copies were determined relative to tissue culture infectious dose
(TCID50) equivalents.
4. Discussion
Several reservoir host infection models have been developed for studying pathogenic hantavirus
infections; Old World Seoul virus infection of Norway rats (Rattus norvegicus) and Puumala virus
infection of bank voles (Myodes glareolus), and two New World viruses, Black Creek Canal virus
infection of cotton rats (Sigmodon hispidus) and SNV infection of deer mice [16,32–35]. Deer mice
can also be infected with ANDV, which is naturally hosted by the long-tailed pygmy rice rat
(Oligoryzomys longicaudatus), but it is cleared after several weeks [21]. Pathogenic Old World
hantaviruses require ABSL-3 containment, whereas New World human pathogenic hantaviruses
require ABSL-4 containment [22], which restricts the number of institutions where such work can
be performed and substantially limits understanding of how New World viruses evade sterilizing
immune responses in reservoir hosts, a critical feature of zoonotic virus ecology.
As natural reservoir hosts of SNV, deer mice remain persistently infected [17], perhaps for
life [13,27,36–38]. Deer mice are one of the only New World reservoir hosts that have been colonized
for hantavirus research. Therefore, we sought to develop an experimental infection model of this
species that can be manipulated under ABSL-3 containment. We chose Maporal virus for our model
because (a) it causes an HCPS-like disease in Syrian hamsters [25] and (b) it is not known to cause
human disease and can, thus, be manipulated in ABSL-3 environments.
In our initial infection experiment to determine susceptibility, we euthanized one male and one
female at various time points and detected viral RNA by PCR in the lungs of all deer mice. A previously
developed ELISA using a highly conserved B cell epitope of Sin Nombre virus nucleocapsid [26,39]
was used to determine antibody titers. Antibodies were detected in one of two deer mice euthanized
on day 14 (male, titer of 200), and both deer mice euthanized on day 56 (titers of 3200 for the male
and 6400 for the female). Only the deer mice euthanized on day 56 had detectable neutralizing
antibodies, with titers of 320 for each. In SNV infection, low-titered ELISA antibodies to nucleocapsid
are detected on day 14 in some deer mice [18], but in ANDV infection all deer mice produce antibodies
by day 14, some with modestly high titers [20,21]. Although slower to develop, deer mice mount a
more robust neutralizing antibody response to SNV (titer range of 160–5620) [16,17] than to ANDV
(range 10–80) [21]. Thus, the deer mouse IgG response to MAPV is more similar to SNV than to ANDV.
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Experimental infection of deer mice with SNV results in detection of viral RNA in many
tissues [16]. In this study, deer mice infected with MAPV also displayed a disseminated infection
pattern at 14 days PI, with virus detected in all organs of all deer mice examined: lung, heart,
spleen, kidney, liver, and salivary gland. The tissue distribution of ANDV in deer mice is less well
characterized, but viral RNA can be detected in lung, heart and spleen to day 21; however, virus is
generally cleared by day 56 [21].
Pathophysiologically, the deer mouse model of MAPV infection recapitulates some of the
histologic features of the cardiopulmonary phase of HCPS in humans and hamsters. The lesions
in the lungs, heart, and liver are not severe enough to precipitate a clinical disease and can be detected
in infected deer mice for 8 weeks PI. Vascular leakage plus acute interstitial pneumonia and single
cardiomyocyte necrosis are central to pathogenesis of MAPV infection in deer mice and resembles
ANDV infection of hamsters [40]. However, it is interesting that histologic lesions are present in
major organ systems despite general lack of unequivocal immunohistochemical reactivity in any of
the involved organs. Previous studies of SNV infection of deer mice encountered such an important
paradox with one major difference that the current model shows pathology in cardiopulmonary
organs [41]. Deer mice experimentally infected with SNV also exhibit mild histopathologic changes
with the presence of viral antigen in the same infected organs [16]; however, ANDV fails to induce
histopathology in deer mice and viral antigen is not detected in tissues [21]. Thus, MAPV infection
of deer mice shares histopathologic similarities with SNV infection but without detection of antigen,
similar to ANDV infection.
Two weeks after experimental infection of deer mice with SNV, only low to modest levels of certain
immune genes that rarely exceed 4-fold elevation occurs [18]. In contrast, two weeks after infection
with ANDV a robust immune gene expression pattern occurs that is qualitatively and quantitatively
distinct, with some genes elevated more than 20-fold, which may account for clearance of ANDV but
not SNV [21]. We examined the expression of 10 cytokine and chemokine genes in MAPV-infected
deer mice that have different patterns and levels in SNV and ANDV infected deer mice. MAPV elicits
an expression pattern more similar to SNV than to ANDV in terms of expression levels. In the spleen,
Ccl2, Ccl3, and Tgfb levels were 2- to 3-fold above that of uninfected control deer mice. Splenic Ccl2
expression is elevated in SNV-infected deer mice but not in ANDV-infected deer mice. Ccl3 expression
in ANDV spleens is about twice that of SNV and MAPV, and Tgfb expression is about four times
greater in ANDV spleens than in SNV- or MAPV-infected spleens. Il23 expression is substantially
downregulated in ANDV- [21] and MAPV-infected spleens, but less so in MAPV infection. Its levels
are unchanged in SNV infected deer mouse spleens [18], thus Il23 expression during MAPV infection
resembles that of ANDV infection.
In lungs, only Ccl3 and Cxcl2 expression were elevated in MAPV infected deer mice. Ccl3 is
elevated in response to ANDV infection, but not SNV infection, whereas Cxcl2 levels are similarly
elevated with MAPV and SNV infection, but much higher in ANDV infection [18,21]. Tgfb expression
was elevated in MAPV-infected deer mice, but because of substantial variation between animals it
was not statistically different. Tgfb is statistically elevated in lungs of both SNV and ANDV infected
deer mice two weeks after infection, but substantially higher in ANDV infection. In the present work,
deer mouse DM20 accounted for much of the Tgfb variation, with a fold-change of 0.76; its removal
from the analysis resulted in statistically elevated Tgfb expression. Thus, although there are several
differences in expression patterns of these genes, the data suggest that MAPV infection of deer mice
more closely resembles that of SNV than ANDV. We have previously reported large variation in gene
expression in deer mice infected with SNV [18] that we attribute, in part, to their outbred status, and
these results are consistent with those findings.
We used endothelial cell medium containing a cocktail of endothelial cell growth factors to
cultivate PMVEC from a 7 day old deer mouse. Immunofluorescence assay (IFA) microscopy suggested
that MAPV may directly transmit to adjacent PMVEC cells (Figure 4). The faster and greater replication
of MAPV in Vero E6 is likely due to the defective type I interferon (IFN) response in these cells that,
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presumably, is intact in the deer mouse PMVEC and likely retards virus replication. However, it is
also possible that the deer mouse PMVEC culture contains other cell types that are not susceptible
to MAPV. Although Vero E6 is deficient in its type I IFN response, hantaviruses can induce type III
IFNλ (IL-29) production in Vero E6 about a week after infection [42], thus it is possible the diffuse
appearance of the day 7 Vero E6 cells may be caused by the presence of IFNλ stimulation of the innate
response. When cellular vs extracellular (i.e., supernatants) levels of viral RNA were examined, Vero
cell supernatants had substantially more vRNA than did its cellular fraction (Figure 5). However,
for the deer mouse PMVEC, the cellular fraction had more vRNA than did the supernatants from day
6 and beyond. This also suggests that MAPV infection of deer mouse PMVEC may occur directly cell
to cell, and that virus cellular shedding may be a minor component in reservoir host endothelial cells.
Further studies are required to determine the mechanisms that account for this observation.
We have determined that deer mice are experimentally susceptible to Maporal virus and that
infection resembles that of SNV, although with some similarities to ANDV (Table 2). In total, 15 deer
mice were inoculated and all became infected. It is the third New World hantavirus that has been
shown to experimentally infect deer mice without precipitating overt clinical disease. However, MAPV
induces mild histopathologic alterations reminiscent of HCPS in humans and which appear to be more
substantial than SNV infection of deer mice. This system will facilitate investigations of a New World
reservoir host response to hantaviruses without requirement for ABSL-4 containment.
Table 2. Comparison of MAPV, Sin Nombre virus (SNV), and Andes virus (ANDV) infection of deer
mice. Traits in boldface reflect those most similar to SNV or ANDV infection of deer mice.
Feature MAPV SNV ANDV
Clinical Disease None None None
Outcome Persistence Persistence Clearance
Nucleocapsid Ab day 14 Some Some All
Neutralizing Ab titer High High Low
Cytokine gene expression Low Low High
Histopathology Minimal-Mild Minimal None
Nucleocapsid IHC None Low None
MAPV causes an HCPS-like disease in Syrian hamsters, thus it should be possible to directly
compare the host responses of a reservoir host species to that of a pathology model using the same
virus. The ability to generate deer mouse primary cell lines that support replication of hantaviruses
could also facilitate examination of homologous hantavirus (SNV) strategies for manipulation of
the host cell response, as well as identification of differences between heterologous hantaviruses.
Evidence has recently accumulated suggesting hantaviruses manipulate the antiviral response of
infected cells [43–46]. However, much of this work has been performed in immortalized human and
nonhuman primate cell lines, and with viral genes cloned into high-expression plasmids that probably
do not reflect nominal levels that occur in infected cells. Considering that MAPV, SNV and ANDV can
infect deer mice, it is likely that these cells are also susceptible to these viruses, and probably other New
World hantaviruses. Together, this could reveal the mechanisms that have evolved in hantaviruses
that lead to persistent infection of the reservoir hosts, and how they may contribute to pathogenesis
in humans.
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